Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US58506Q1094
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG0065B7K59
MEDP
Medpace Holdings Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Medpace Holdings Inc
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
Do., 07.05.2026       Medpace
US58506Q1094

SAN DIEGO, May 7, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace cla...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 7, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

Notice to Pension Funds, Asset Managers, and FiduciariesNEW YORK, May 7, 2026 /PRNewswire/ -- Institutional investors holding positions in Medpace Holdings Inc. (NASDAQ: MEDP) during the period April 22, 2025 through February 9, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional in...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Me...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 07.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 06.05.2026       Medpace
US58506Q1094

BENSALEM, Pa., May 6, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP), CO...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 06.05.2026       Medpace
US58506Q1094

Executive Accountability: Jesse J. Geiger Named in Securities ActionNEW YORK, May 6, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors that Jesse J. Geiger, President of Medpace Holdings Inc. (NASDAQ: MEDP), is named as a defendant in a securities class action covering purchases between April 22, 2025 and February 9, 2026. Find out...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 05.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Medpace
US58506Q1094

NEW YORK, May 5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 05.05.2026       Medpace
US58506Q1094

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.NEW YORK, May 5, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 4, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 4, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 04.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 4, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholde...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Sa., 02.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Fr., 01.05.2026       Medpace
US58506Q1094

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail a...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 30.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive, (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 30.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 30, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 30.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 30.04.2026       Medpace
US58506Q1094

Time-Sensitive: Allegations Focus on Misrepresentations About Backlog Cancellation BehaviorNEW YORK, April 30, 2026 /PRNewswire/ -- SueWallSt alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) that a pending securities class action has been filed on behalf of shareholders who purchased securities between April 22, 2025 and February 9, 2026....
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 30.04.2026       Medpace
US58506Q1094

SAN DIEGO, April 29, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientif...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 29, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violatio...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Medpace
US58506Q1094

From Optimism to Disillusionment: How Investor Sentiment Shifted on MEDPNEW YORK, April 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP provides context on the evolution of investor sentiment surrounding Medpace Holdings Inc. (NASDAQ: MEDP) and a pending securities class action covering purchases between April 22, 2025 and February 9, 2026. Fin...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 29.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 28.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 28.04.2026       Medpace
US58506Q1094

NEW YORK, April 28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 28.04.2026       Medpace
US58506Q1094

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged to act by June 8, 2026.NEW YORK, April 28, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class act...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Di., 28.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 27.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mo., 27.04.2026       Medpace
US58506Q1094

San Diego, California--(Newsfile Corp. - April 27, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the Medpace...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
So., 26.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
So., 26.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Sa., 25.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Fr., 24.04.2026       Medpace
US58506Q1094

NEW YORK, April 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Fr., 24.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)....
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Fr., 24.04.2026       Medpace
US58506Q1094

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Me...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Fr., 24.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 23.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This pres...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 23.04.2026       Medpace
US58506Q1094

Key Dates and Disclosure Events Shareholders Need to KnowNEW YORK, April 23, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Medpace Holdings Inc. (NASDAQ: MEDP) to contact the firm. Those who purchased Medpace securities between April 22, 2025 and February 9, 2026 may be entitled to recover damages. Find out if you are...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Do., 23.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Results Revenue for the three months ended March 31, 2026 increased 26.5% to $706.6 million, compared to $558.6 million for the comparable prior-year period. On a constant currency basis,...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Medpace
US58506Q1094

BENSALEM, Pa., April 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP),...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Medpace
US58506Q1094

Promise vs. Reality: The Medpace Performance GapNEW YORK, April 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP highlights the contrast between Medpace Holdings Inc.'s (NASDAQ: MEDP) promises and results. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500....
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink
Mi., 22.04.2026       Medpace
US58506Q1094

SAN DIEGO, April 21, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Ca...
Zur Nachricht
Medpace
Charts & Research Termsheets Terminal
Permalink